-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, colorectal cancer has become one of the common malignant tumors in China, and its incidence ranks third among malignant tumo.
The results released by the project "Survey on the Status of Diagnosis and Treatment of Patients with Advanced Colorectal Cancer in China" show that 83% of colorectal cancer patients in China were in the middle and late stages when they were first diagnosed, and 44% of the patients had already developed liver, lung and other metastas.
A survey found that 64% of the patients were completely unaware of the risk factors for colorectal cancer before they got sick, and 85% of the patients did not know the knowledge of early screening for colorectal canc.
Understanding risk factors and early diagnosis is very beneficial for the prevention and treatment of colorectal canc.
However, due to lack of awareness of screening, embarrassment and pain of colonoscopy, and other reasons, key populations are reluctant to screen, delaying the best time for diagnosis and treatme.
Experimental studies have shown that the detection sensitivity, specificity and total coincidence rate of Ruichangtai® (intestinal cancer stool gene detection) are all higher than 9
Early screening of colorectal cancer is very important to prevent colorectal cancer, and the use of non-invasive, painless, high-sensitivity Ruichangtai® (colorectal cancer stool genetic test) is helpful for early screening of colorectal cancer, which can reduce the incidence of colorectal cancer to a certain exte.
